Sarah Boyce's Net Worth
$33 Million
Who is Sarah Boyce?
Sarah Boyce has an estimated net worth of $33 Million. This is based on reported shares across multiple companies, which include Berkeley Lights, Inc., LIGAND PHARMACEUTICALS INC, Avidity Biosciences, Inc., ISIS PHARMACEUTICALS INC, AKCEA THERAPEUTICS, INC., OmniAb, Inc., and Contineum Therapeutics, Inc..
SEC CIK
Sarah Boyce's CIK is 0001629383
Past Insider Trading and Trends
2024 was Sarah Boyce's most active year for acquiring shares with 19 total transactions. Sarah Boyce's most active month to acquire stocks was the month of December. 2024 was Sarah Boyce's most active year for disposing of shares, totalling 25 transactions. Sarah Boyce's most active month to dispose stocks was the month of February. 2024 saw Sarah Boyce paying a total of $788,640.00 for 1,233,000 shares, this is the most they've acquired in one year. In 2024 Sarah Boyce cashed out on 1,329,166 shares for a total of $21,566,278.18, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Berkeley Lights, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.4K |
—
|
—
| 1.4K |
May 14
| |||
Form 4
|
—
|
0
|
$35.02 | -$522,336.80 |
0
|
Scheduled
|
Mar 1
| ||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
LIGAND PHARMACEUTICALS INC (LGND) Snapshot price: $101.14
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -25.77% | -1.00K |
—
|
—
| 2.89K |
Nov 1
| |||
Form 4
| +34.72% | 1K |
—
|
—
| 3.9K |
Jun 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Avidity Biosciences, Inc. (RNA) Snapshot price: $40.46
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$22.30 | -$1,179,102.40 | 205.04K |
Scheduled
|
Aug 6
| ||
Form 4
|
—
|
0
|
$20.59 | -$1,083,362.00 | 205.04K |
Scheduled
|
Jul 9
| ||
Form 4
| +82.88% | 92.93K |
$39.13 | -$1,255,039.58 | 205.04K |
Scheduled
|
Jun 17 - Jun 18
| ||
Form 4
|
—
|
0
|
$19.94 | -$11,216,305.84 | 112.12K |
Scheduled
|
Jun 12 - Jun 14
| ||
Form 4
|
—
|
0
|
$14.33 | -$733,059.60 | 112.12K |
Scheduled
|
Jun 4
| ||
Form 4
|
—
|
0
|
$13.39 | -$680,330.00 | 112.12K |
Scheduled
|
May 7
| ||
Form 4
|
—
|
0
|
$13.75 | -$700,198.80 | 112.12K |
Scheduled
|
Apr 2
| ||
Form 4
|
—
|
0
|
$11.47 | -$2,291,511.60 | 112.12K |
Scheduled
|
Mar 8 - Mar 12
| ||
Form 4
|
—
|
0
|
$10.68 | -$1,587,146.40 | 112.12K |
Scheduled
|
Mar 1
| ||
Form 4
| +106.69% | 57.41K |
$10.13 | -$51,581.96 | 111.22K |
Scheduled
|
Jan 20 - Jan 22
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 11
| |||
Form 4
|
—
|
0
|
$12.80 | -$1,155,726.80 | 53.35K |
Scheduled
|
Feb 1 - Feb 3
| ||
Form 4
| +1,491.65% | 50K |
—
|
—
| 53.35K |
Jan 20
| |||
Form 4
|
—
|
0
|
$12.06 | -$1,079,738.36 |
0
|
Scheduled
|
Aug 24 - Aug 25
| ||
Form 4
|
—
|
0
|
$11.85 | -$2,123.00 |
0
|
Scheduled
|
Aug 15
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ISIS PHARMACEUTICALS INC (IONS) Snapshot price: $46.89
Chief Business Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +55.05% | 3.17K |
$51.76 | -$113,664.96 | 8.93K |
Jan 15 - Jan 16
| |||
Form 4
| +9.32% | 491 |
$42.76 | $20,992.71 | 5.76K |
Jan 1 - Jan 2
| |||
Form 4
| +0.32% | 17 |
$40.66 | $691.14 | 5.27K |
Jul 1
| |||
Form 4
| +67.80% | 2.12K |
$46.29 | -$63,000.69 | 5.25K |
Jan 15 - Jan 17
| |||
Form 4
| +46.40% | 992 |
$20.76 | $20,590.94 | 3.13K |
Jan 1 - Jan 3
| |||
Form 4
| +23.23% | 403 |
$20.76 | $8,365.07 | 2.14K |
Jul 1
| |||
Form 4
| +314.08% | 1.32K |
$41.46 | -$36,150.85 | 1.74K |
Jan 15 - Jan 19
| |||
Form 4
|
∞
| 419 |
$47.71 | $19,990.70 | 419 |
Jan 1 - Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AKCEA THERAPEUTICS, INC. No price found
President
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -8.38% | -1.82K |
$23.52 | -$42,782.88 | 19.89K |
Jul 15
| |||
Form 4
| +3.89% | 813 |
$20.04 | $16,294.96 | 21.71K |
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
∞
| 20.89K |
—
|
—
| 20.89K |
Apr 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||